Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Psyched Wellness makes pre-clinical progress with its Amanita Muscaria-derived wellness product

Psyched Wellness makes pre-clinical progress with its Amanita Muscaria-derived wellness product

Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) CEO Jeff Stevens tells Proactive the Canadian-based health supplements company specializing in mushroom-derived products is making progress with its Amanita Muscaria mushroom extract.

Stevens says the group has begun pre-clinical studios with Amanita Muscaria, and will look to apply to the FDA as a dietary ingredient and Health Canada for a natural health product when it is completed.